Trials / Completed
CompletedNCT06668506
To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
A Multi-center, Prospective, Observational Study to Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,814 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the improvement effect on subjective symptoms of gastritis and adverse events through patient self-assessment results (PRO) by conducting follow-up observations for patients with gastritis at 2 to 4 weeks after administration of Mucotra® SR tablets.
Conditions
Timeline
- Start date
- 2022-03-17
- Primary completion
- 2022-11-03
- Completion
- 2024-03-13
- First posted
- 2024-10-31
- Last updated
- 2024-11-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06668506. Inclusion in this directory is not an endorsement.